Rank | Gene Set | Z-score |
---|---|---|
1 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.93610024 |
2 | positive regulation of mitochondrial fission (GO:0090141) | 4.87931307 |
3 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.35223970 |
4 | neutrophil activation (GO:0042119) | 4.01861033 |
5 | transferrin transport (GO:0033572) | 4.01127539 |
6 | phagosome maturation (GO:0090382) | 3.95383335 |
7 | inositol phosphate catabolic process (GO:0071545) | 3.91479419 |
8 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.80745979 |
9 | ferric iron transport (GO:0015682) | 3.76882069 |
10 | trivalent inorganic cation transport (GO:0072512) | 3.76882069 |
11 | protein neddylation (GO:0045116) | 3.74485067 |
12 | negative regulation of mast cell activation (GO:0033004) | 3.73711447 |
13 | negative regulation of cell killing (GO:0031342) | 3.57134908 |
14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57134908 |
15 | granulocyte activation (GO:0036230) | 3.56695753 |
16 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.55507138 |
17 | tolerance induction (GO:0002507) | 3.52593122 |
18 | myoblast migration (GO:0051451) | 3.52278891 |
19 | signal peptide processing (GO:0006465) | 3.41833818 |
20 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.39097920 |
21 | negative regulation of dendrite development (GO:2000171) | 3.36251948 |
22 | neutrophil activation involved in immune response (GO:0002283) | 3.32353790 |
23 | ER overload response (GO:0006983) | 3.31867137 |
24 | regulation of mitochondrial fission (GO:0090140) | 3.31588274 |
25 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30815311 |
26 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30815311 |
27 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.30068071 |
28 | thrombin receptor signaling pathway (GO:0070493) | 3.28384660 |
29 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.22844942 |
30 | positive regulation of granulocyte differentiation (GO:0030854) | 3.22825404 |
31 | serotonin receptor signaling pathway (GO:0007210) | 3.17872158 |
32 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.16765599 |
33 | protein deneddylation (GO:0000338) | 3.13490664 |
34 | regulation of regulatory T cell differentiation (GO:0045589) | 3.12289595 |
35 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.12162727 |
36 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.09038310 |
37 | histamine secretion (GO:0001821) | 3.08533359 |
38 | regulation of platelet aggregation (GO:0090330) | 2.99009614 |
39 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.95824735 |
40 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.95824735 |
41 | chaperone-mediated protein transport (GO:0072321) | 2.95550819 |
42 | activated T cell proliferation (GO:0050798) | 2.93328467 |
43 | positive regulation of mast cell activation (GO:0033005) | 2.91658944 |
44 | mast cell activation (GO:0045576) | 2.91448722 |
45 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.91429808 |
46 | inositol phosphate dephosphorylation (GO:0046855) | 2.91429808 |
47 | cullin deneddylation (GO:0010388) | 2.89317528 |
48 | regulation of memory T cell differentiation (GO:0043380) | 2.88251616 |
49 | peripheral nervous system neuron development (GO:0048935) | 2.87532337 |
50 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.86697102 |
51 | cellular response to interleukin-15 (GO:0071350) | 2.83750860 |
52 | leukocyte degranulation (GO:0043299) | 2.82245651 |
53 | superoxide anion generation (GO:0042554) | 2.81851678 |
54 | presynaptic membrane assembly (GO:0097105) | 2.81712948 |
55 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.80422466 |
56 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.80422466 |
57 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 2.76305966 |
58 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 2.76305966 |
59 | regulation of synaptic vesicle transport (GO:1902803) | 2.75472451 |
60 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.74430049 |
61 | regulation of mast cell activation (GO:0033003) | 2.72815283 |
62 | negative T cell selection (GO:0043383) | 2.72128550 |
63 | regulation of hexokinase activity (GO:1903299) | 2.69168946 |
64 | regulation of glucokinase activity (GO:0033131) | 2.69168946 |
65 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.69016882 |
66 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.68277556 |
67 | cellular response to gamma radiation (GO:0071480) | 2.68275361 |
68 | positive regulation of B cell differentiation (GO:0045579) | 2.67527821 |
69 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.66009167 |
70 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.63485855 |
71 | iron ion transport (GO:0006826) | 2.61956301 |
72 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.61689186 |
73 | intracellular pH reduction (GO:0051452) | 2.61193811 |
74 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.60992882 |
75 | regulation of female gonad development (GO:2000194) | 2.60241567 |
76 | regulation of gamma-delta T cell activation (GO:0046643) | 2.59833408 |
77 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.59685244 |
78 | regulation of meiosis I (GO:0060631) | 2.59650516 |
79 | myeloid cell activation involved in immune response (GO:0002275) | 2.59077889 |
80 | viral protein processing (GO:0019082) | 2.58979222 |
81 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.58423921 |
82 | response to interleukin-15 (GO:0070672) | 2.56979911 |
83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.55837514 |
84 | cellular extravasation (GO:0045123) | 2.55759601 |
85 | negative thymic T cell selection (GO:0045060) | 2.55143076 |
86 | RNA destabilization (GO:0050779) | 2.54807114 |
87 | positive regulation of steroid hormone secretion (GO:2000833) | 2.53878112 |
88 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.53769548 |
89 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53380283 |
90 | regulation of RIG-I signaling pathway (GO:0039535) | 2.51689557 |
91 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.51486482 |
92 | interferon-gamma production (GO:0032609) | 2.49317096 |
93 | negative regulation of signal transduction by p53 class mediator (GO:1901797) | 2.48971015 |
94 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.48805280 |
95 | dendritic cell migration (GO:0036336) | 2.48227894 |
96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.47351988 |
97 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.46979492 |
98 | eosinophil chemotaxis (GO:0048245) | 2.46813360 |
99 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.46241291 |
100 | negative regulation of membrane potential (GO:0045837) | 2.45976796 |
101 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.45689336 |
102 | piRNA metabolic process (GO:0034587) | 2.45460805 |
103 | autophagic vacuole fusion (GO:0000046) | 2.44909741 |
104 | negative regulation of T cell mediated immunity (GO:0002710) | 2.43526766 |
105 | organelle membrane fusion (GO:0090174) | 2.42913418 |
106 | microglial cell activation (GO:0001774) | 2.41923684 |
107 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 2.41863040 |
108 | positive regulation of DNA recombination (GO:0045911) | 2.41782416 |
109 | presynaptic membrane organization (GO:0097090) | 2.41359194 |
110 | immunoglobulin mediated immune response (GO:0016064) | 2.40230092 |
111 | polyol catabolic process (GO:0046174) | 2.39969487 |
112 | pH reduction (GO:0045851) | 2.38876458 |
113 | protein-cofactor linkage (GO:0018065) | 2.38412839 |
114 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.37835228 |
115 | protein localization to cilium (GO:0061512) | 2.37762277 |
116 | regulation of platelet activation (GO:0010543) | 2.37596555 |
117 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.37394409 |
118 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.36852288 |
119 | relaxation of smooth muscle (GO:0044557) | 2.35591467 |
120 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.35472311 |
121 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.35309344 |
122 | actin nucleation (GO:0045010) | 2.35071517 |
123 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.34397174 |
124 | positive regulation of mitochondrial membrane permeability (GO:0035794) | 2.34198450 |
125 | regulation of mast cell degranulation (GO:0043304) | 2.33240208 |
126 | regulation of establishment of cell polarity (GO:2000114) | 2.33236858 |
127 | megakaryocyte development (GO:0035855) | 2.33228370 |
128 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.32592352 |
129 | maturation of 5.8S rRNA (GO:0000460) | 2.32178993 |
130 | lipoxygenase pathway (GO:0019372) | 2.31391798 |
131 | sequestering of actin monomers (GO:0042989) | 2.30875147 |
132 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.30758929 |
133 | cytochrome complex assembly (GO:0017004) | 2.30514532 |
134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.29559183 |
135 | histamine transport (GO:0051608) | 2.29062025 |
136 | positive regulation of mast cell degranulation (GO:0043306) | 2.28920215 |
137 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.28920215 |
138 | striatum development (GO:0021756) | 2.28172228 |
139 | response to hyperoxia (GO:0055093) | 2.26677277 |
140 | response to increased oxygen levels (GO:0036296) | 2.26677277 |
141 | multicellular organism reproduction (GO:0032504) | 2.26297290 |
142 | neutrophil mediated immunity (GO:0002446) | 2.26023621 |
143 | negative regulation of alpha-beta T cell differentiation (GO:0046639) | 2.26022306 |
144 | regulation of homotypic cell-cell adhesion (GO:0034110) | 2.25997300 |
145 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.25563612 |
146 | regulation of interleukin-17 production (GO:0032660) | 2.25318727 |
147 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.25093540 |
148 | positive regulation of humoral immune response (GO:0002922) | 2.24876367 |
149 | negative regulation of interleukin-17 production (GO:0032700) | 2.24857343 |
150 | reactive oxygen species biosynthetic process (GO:1903409) | 2.24851425 |
151 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.24666766 |
152 | sleep (GO:0030431) | 2.24197929 |
153 | negative regulation of adaptive immune response (GO:0002820) | 2.24014981 |
154 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.23877735 |
155 | dendritic cell chemotaxis (GO:0002407) | 2.23587328 |
156 | regulation of B cell differentiation (GO:0045577) | 2.23338534 |
157 | platelet dense granule organization (GO:0060155) | 2.23227756 |
158 | myeloid leukocyte mediated immunity (GO:0002444) | 2.23151682 |
159 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.22971489 |
160 | T cell receptor signaling pathway (GO:0050852) | 2.22735963 |
161 | regulation of cell maturation (GO:1903429) | 2.22196335 |
162 | protein complex biogenesis (GO:0070271) | 2.22165687 |
163 | vesicle fusion (GO:0006906) | 2.22119712 |
164 | regulation of germinal center formation (GO:0002634) | 2.21884384 |
165 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 2.21277563 |
166 | neuronal action potential propagation (GO:0019227) | 2.20732672 |
167 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.20659751 |
168 | regulation of amino acid transport (GO:0051955) | 2.20386477 |
169 | protein K11-linked deubiquitination (GO:0035871) | 2.19966843 |
170 | glycosphingolipid catabolic process (GO:0046479) | 2.19963500 |
171 | positive regulation of isotype switching (GO:0045830) | 2.19867157 |
172 | negative regulation of exocytosis (GO:0045920) | 2.19740736 |
173 | retinal cone cell development (GO:0046549) | 2.19378180 |
174 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.18564222 |
175 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.17707376 |
176 | regulation of activation of Janus kinase activity (GO:0010533) | 2.17037089 |
177 | positive T cell selection (GO:0043368) | 2.16913073 |
178 | positive regulation of B cell mediated immunity (GO:0002714) | 2.16892366 |
179 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.16892366 |
180 | negative regulation of B cell activation (GO:0050869) | 2.16789282 |
181 | regulation of female receptivity (GO:0045924) | 2.15880694 |
182 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.15576603 |
183 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.15576603 |
184 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.15030501 |
185 | B cell mediated immunity (GO:0019724) | 2.14738682 |
186 | regulation of DNA methylation (GO:0044030) | 2.14291210 |
187 | respiratory burst (GO:0045730) | 2.13127999 |
188 | neuronal action potential (GO:0019228) | 2.12215622 |
189 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.12201415 |
190 | negative regulation of cation channel activity (GO:2001258) | 2.11590278 |
191 | regulation of fever generation (GO:0031620) | 2.10510140 |
192 | eosinophil migration (GO:0072677) | 2.10326368 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.73452625 |
2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.71591093 |
3 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.52681143 |
4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.33769183 |
5 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.11394131 |
6 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.98471942 |
7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.92557579 |
8 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.89055805 |
9 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.68102305 |
10 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.66936862 |
11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.53819672 |
12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.46799847 |
13 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.43762188 |
14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.24365669 |
15 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.19517710 |
16 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.14299790 |
17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.05093969 |
18 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.96080173 |
19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94788146 |
20 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.93329159 |
21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.92938090 |
22 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88624580 |
23 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.82835608 |
24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82335592 |
25 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.81611006 |
26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.78982916 |
27 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.77615220 |
28 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.75711864 |
29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.74192241 |
30 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.72959359 |
31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.72492932 |
32 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.71381720 |
33 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.70538579 |
34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.69631670 |
35 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.66541067 |
36 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.65673192 |
37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.65365224 |
38 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.64723510 |
39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.63996679 |
40 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.62991592 |
41 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.62429497 |
42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.62179493 |
43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.61860228 |
44 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.61298385 |
45 | MYB_26560356_Chip-Seq_TH2_Human | 1.61239799 |
46 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.60296105 |
47 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.59665357 |
48 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.58310074 |
49 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.55108909 |
50 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.55108909 |
51 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.54724648 |
52 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.54649380 |
53 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.54242497 |
54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.52501006 |
55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.51915428 |
56 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.51605429 |
57 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49787586 |
58 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.49744361 |
59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.48098742 |
60 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.46962027 |
61 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.46928528 |
62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46412520 |
63 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.45555147 |
64 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44995922 |
65 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.44444477 |
66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.42824698 |
67 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.41290926 |
68 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.40606631 |
69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40397741 |
70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.39638465 |
71 | * JUN_21703547_ChIP-Seq_K562_Human | 1.39180737 |
72 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.39081418 |
73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.37846363 |
74 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37686491 |
75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37532147 |
76 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33720921 |
77 | EWS_26573619_Chip-Seq_HEK293_Human | 1.33613087 |
78 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.32719563 |
79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.32112731 |
80 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.30069727 |
81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.29599698 |
82 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29248735 |
83 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.24754800 |
84 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.24732839 |
85 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23862935 |
86 | * TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.23689558 |
87 | * SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23565286 |
88 | * NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23565286 |
89 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.21226093 |
90 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.18182424 |
91 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.17548838 |
92 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.17318385 |
93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.15452487 |
94 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.15328084 |
95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.14957640 |
96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14763468 |
97 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.13982897 |
98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.13814161 |
99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.13287980 |
100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.12632069 |
101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.11343081 |
102 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10954359 |
103 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.10939510 |
104 | FUS_26573619_Chip-Seq_HEK293_Human | 1.10900729 |
105 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10742591 |
106 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.09909012 |
107 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09884749 |
108 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.09794038 |
109 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.08785065 |
110 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08576877 |
111 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.08428770 |
112 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08326629 |
113 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07273762 |
114 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.06784282 |
115 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06310197 |
116 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.06236847 |
117 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.03990250 |
118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03516333 |
119 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01803000 |
120 | * CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00989085 |
121 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.00975288 |
122 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.99421033 |
123 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98313109 |
124 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.98313109 |
125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97909743 |
126 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97710444 |
127 | TCF4_23295773_ChIP-Seq_U87_Human | 0.97471833 |
128 | MYB_26560356_Chip-Seq_TH1_Human | 0.97468481 |
129 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.97468001 |
130 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.97021867 |
131 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96953567 |
132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.96425990 |
133 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.96217832 |
134 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.95655675 |
135 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.94712603 |
136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.94666650 |
137 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.94238684 |
138 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.94156945 |
139 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.93988599 |
140 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93678320 |
141 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93601219 |
142 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.93230713 |
143 | SPI1_23127762_ChIP-Seq_K562_Human | 0.92206751 |
144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91241789 |
145 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90688691 |
146 | * CDX2_22108803_ChIP-Seq_LS180_Human | 0.90442944 |
147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89297395 |
148 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.88550905 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001986_abnormal_taste_sensitivity | 5.12692643 |
2 | MP0005464_abnormal_platelet_physiology | 3.76931825 |
3 | MP0002876_abnormal_thyroid_physiology | 3.25781690 |
4 | MP0010386_abnormal_urinary_bladder | 3.03471263 |
5 | MP0005646_abnormal_pituitary_gland | 2.85584609 |
6 | MP0002735_abnormal_chemical_nociception | 2.83757911 |
7 | MP0003880_abnormal_central_pattern | 2.75086779 |
8 | MP0006276_abnormal_autonomic_nervous | 2.64450709 |
9 | MP0000465_gastrointestinal_hemorrhage | 2.60580670 |
10 | MP0003787_abnormal_imprinting | 2.55473715 |
11 | MP0001968_abnormal_touch/_nociception | 2.48786646 |
12 | MP0002736_abnormal_nociception_after | 2.47845532 |
13 | MP0001984_abnormal_olfaction | 2.45347262 |
14 | MP0009697_abnormal_copulation | 2.42490622 |
15 | MP0004270_analgesia | 2.36748919 |
16 | MP0003183_abnormal_peptide_metabolism | 2.30414341 |
17 | MP0008004_abnormal_stomach_pH | 2.29413307 |
18 | MP0001905_abnormal_dopamine_level | 2.23696479 |
19 | MP0001800_abnormal_humoral_immune | 2.22395916 |
20 | MP0002734_abnormal_mechanical_nocicepti | 2.20500337 |
21 | MP0004782_abnormal_surfactant_physiolog | 2.20132934 |
22 | MP0008260_abnormal_autophagy | 2.20066152 |
23 | MP0003303_peritoneal_inflammation | 2.08117029 |
24 | MP0001835_abnormal_antigen_presentation | 2.05828127 |
25 | MP0002877_abnormal_melanocyte_morpholog | 2.03055681 |
26 | MP0001188_hyperpigmentation | 2.02026444 |
27 | MP0002148_abnormal_hypersensitivity_rea | 2.01478230 |
28 | MP0003724_increased_susceptibility_to | 1.98096243 |
29 | MP0002163_abnormal_gland_morphology | 1.96348731 |
30 | MP0000685_abnormal_immune_system | 1.90223011 |
31 | MP0008877_abnormal_DNA_methylation | 1.88515553 |
32 | MP0002420_abnormal_adaptive_immunity | 1.87625387 |
33 | MP0001819_abnormal_immune_cell | 1.85566959 |
34 | MP0003718_maternal_effect | 1.83830386 |
35 | MP0006054_spinal_hemorrhage | 1.81477119 |
36 | MP0005310_abnormal_salivary_gland | 1.73337032 |
37 | MP0002277_abnormal_respiratory_mucosa | 1.70587934 |
38 | MP0001542_abnormal_bone_strength | 1.69239116 |
39 | MP0003763_abnormal_thymus_physiology | 1.68738431 |
40 | MP0009745_abnormal_behavioral_response | 1.66511117 |
41 | MP0003828_pulmonary_edema | 1.65082476 |
42 | MP0009046_muscle_twitch | 1.62155591 |
43 | MP0010155_abnormal_intestine_physiology | 1.57976922 |
44 | MP0001501_abnormal_sleep_pattern | 1.55583830 |
45 | MP0002138_abnormal_hepatobiliary_system | 1.54866744 |
46 | MP0009785_altered_susceptibility_to | 1.54225077 |
47 | MP0003195_calcinosis | 1.54115341 |
48 | MP0005171_absent_coat_pigmentation | 1.53698362 |
49 | MP0002398_abnormal_bone_marrow | 1.51336024 |
50 | MP0005379_endocrine/exocrine_gland_phen | 1.50658757 |
51 | MP0001529_abnormal_vocalization | 1.50569483 |
52 | MP0002638_abnormal_pupillary_reflex | 1.49264904 |
53 | MP0002009_preneoplasia | 1.48111377 |
54 | MP0002063_abnormal_learning/memory/cond | 1.47431317 |
55 | MP0000716_abnormal_immune_system | 1.37862460 |
56 | MP0005410_abnormal_fertilization | 1.37476345 |
57 | MP0001845_abnormal_inflammatory_respons | 1.37340764 |
58 | MP0002572_abnormal_emotion/affect_behav | 1.36052716 |
59 | MP0003635_abnormal_synaptic_transmissio | 1.35328349 |
60 | MP0001851_eye_inflammation | 1.32200694 |
61 | MP0000689_abnormal_spleen_morphology | 1.32162938 |
62 | MP0002419_abnormal_innate_immunity | 1.31597554 |
63 | MP0001970_abnormal_pain_threshold | 1.30702996 |
64 | MP0005408_hypopigmentation | 1.30603863 |
65 | MP0003186_abnormal_redox_activity | 1.30563734 |
66 | MP0002405_respiratory_system_inflammati | 1.29109915 |
67 | MP0004947_skin_inflammation | 1.28364559 |
68 | MP0002064_seizures | 1.26927964 |
69 | MP0003866_abnormal_defecation | 1.26919484 |
70 | MP0002733_abnormal_thermal_nociception | 1.26128612 |
71 | MP0002132_abnormal_respiratory_system | 1.26047126 |
72 | MP0005671_abnormal_response_to | 1.25779020 |
73 | MP0004859_abnormal_synaptic_plasticity | 1.25655694 |
74 | MP0002272_abnormal_nervous_system | 1.25645194 |
75 | MP0000372_irregular_coat_pigmentation | 1.23803173 |
76 | MP0001502_abnormal_circadian_rhythm | 1.23721885 |
77 | MP0005000_abnormal_immune_tolerance | 1.23196127 |
78 | MP0002102_abnormal_ear_morphology | 1.22571657 |
79 | MP0000015_abnormal_ear_pigmentation | 1.18363025 |
80 | MP0002067_abnormal_sensory_capabilities | 1.17567469 |
81 | MP0008995_early_reproductive_senescence | 1.16382057 |
82 | MP0003656_abnormal_erythrocyte_physiolo | 1.11777452 |
83 | MP0002722_abnormal_immune_system | 1.11427160 |
84 | MP0004484_altered_response_of | 1.09972503 |
85 | MP0003300_gastrointestinal_ulcer | 1.09489000 |
86 | MP0005451_abnormal_body_composition | 1.08808295 |
87 | MP0001440_abnormal_grooming_behavior | 1.07861561 |
88 | MP0005645_abnormal_hypothalamus_physiol | 1.04257909 |
89 | MP0001853_heart_inflammation | 1.04249825 |
90 | MP0002166_altered_tumor_susceptibility | 1.03134806 |
91 | MP0001919_abnormal_reproductive_system | 1.02445470 |
92 | MP0002429_abnormal_blood_cell | 1.02104883 |
93 | MP0001545_abnormal_hematopoietic_system | 1.01077499 |
94 | MP0005397_hematopoietic_system_phenotyp | 1.01077499 |
95 | MP0008872_abnormal_physiological_respon | 0.97985466 |
96 | MP0003436_decreased_susceptibility_to | 0.97662364 |
97 | MP0003646_muscle_fatigue | 0.97170568 |
98 | MP0001119_abnormal_female_reproductive | 0.96236728 |
99 | MP0003879_abnormal_hair_cell | 0.96148617 |
100 | MP0005535_abnormal_body_temperature | 0.96073231 |
101 | MP0000538_abnormal_urinary_bladder | 0.95678710 |
102 | MP0004924_abnormal_behavior | 0.95045277 |
103 | MP0005386_behavior/neurological_phenoty | 0.95045277 |
104 | MP0004883_abnormal_blood_vessel | 0.93868302 |
105 | MP0004510_myositis | 0.93787035 |
106 | MP0001177_atelectasis | 0.92904626 |
107 | MP0000249_abnormal_blood_vessel | 0.92904534 |
108 | MP0009764_decreased_sensitivity_to | 0.92881311 |
109 | MP0005167_abnormal_blood-brain_barrier | 0.92572668 |
110 | MP0004142_abnormal_muscle_tone | 0.91930940 |
111 | MP0009763_increased_sensitivity_to | 0.90419888 |
112 | MP0000703_abnormal_thymus_morphology | 0.90231563 |
113 | MP0000681_abnormal_thyroid_gland | 0.88255312 |
114 | MP0005387_immune_system_phenotype | 0.87328800 |
115 | MP0001790_abnormal_immune_system | 0.87328800 |
116 | MP0003172_abnormal_lysosome_physiology | 0.86931457 |
117 | MP0002160_abnormal_reproductive_system | 0.86767209 |
118 | MP0005084_abnormal_gallbladder_morpholo | 0.86181563 |
119 | MP0001486_abnormal_startle_reflex | 0.85980274 |
120 | MP0001765_abnormal_ion_homeostasis | 0.85978682 |
121 | MP0002822_catalepsy | 0.84585920 |
122 | MP0005075_abnormal_melanosome_morpholog | 0.84513280 |
123 | MP0009333_abnormal_splenocyte_physiolog | 0.83845113 |
124 | MP0001764_abnormal_homeostasis | 0.83059287 |
125 | MP0009765_abnormal_xenobiotic_induced | 0.81070291 |
126 | MP0005164_abnormal_response_to | 0.79498729 |
127 | MP0008469_abnormal_protein_level | 0.79295067 |
128 | MP0001963_abnormal_hearing_physiology | 0.79257751 |
129 | MP0005551_abnormal_eye_electrophysiolog | 0.78996456 |
130 | MP0003075_altered_response_to | 0.78848032 |
131 | MP0005389_reproductive_system_phenotype | 0.78350976 |
132 | MP0001879_abnormal_lymphatic_vessel | 0.78337161 |
133 | MP0000343_altered_response_to | 0.77791383 |
134 | MP0003191_abnormal_cellular_cholesterol | 0.77787099 |
135 | MP0006292_abnormal_olfactory_placode | 0.76183964 |
136 | MP0002184_abnormal_innervation | 0.75038725 |
137 | MP0002693_abnormal_pancreas_physiology | 0.74876775 |
138 | MP0005166_decreased_susceptibility_to | 0.74793945 |
139 | MP0008961_abnormal_basal_metabolism | 0.74635517 |
140 | MP0006082_CNS_inflammation | 0.73381499 |
141 | MP0000230_abnormal_systemic_arterial | 0.72941103 |
142 | MP0005395_other_phenotype | 0.70377759 |
143 | MP0002998_abnormal_bone_remodeling | 0.70293829 |
144 | MP0005025_abnormal_response_to | 0.70049779 |
145 | MP0002933_joint_inflammation | 0.69250315 |
146 | MP0009278_abnormal_bone_marrow | 0.69234882 |
147 | MP0001533_abnormal_skeleton_physiology | 0.67620849 |
148 | MP0008007_abnormal_cellular_replicative | 0.66334575 |
149 | MP0002557_abnormal_social/conspecific_i | 0.65547759 |
150 | MP0002751_abnormal_autonomic_nervous | 0.64548669 |
151 | MP0002452_abnormal_antigen_presenting | 0.62601707 |
152 | MP0002723_abnormal_immune_serum | 0.61826046 |
153 | MP0004742_abnormal_vestibular_system | 0.61782460 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Stomatitis (HP:0010280) | 5.56161039 |
2 | Hypothermia (HP:0002045) | 5.37122623 |
3 | Prolonged bleeding time (HP:0003010) | 5.04960251 |
4 | Abnormal hair whorl (HP:0010721) | 4.55094840 |
5 | Petechiae (HP:0000967) | 4.18562249 |
6 | Focal motor seizures (HP:0011153) | 4.00038392 |
7 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.68727627 |
8 | Epistaxis (HP:0000421) | 3.66311200 |
9 | Febrile seizures (HP:0002373) | 3.62775677 |
10 | Gingival bleeding (HP:0000225) | 3.40158879 |
11 | Menorrhagia (HP:0000132) | 3.38403722 |
12 | Abnormal platelet volume (HP:0011876) | 3.32073696 |
13 | Increased mean platelet volume (HP:0011877) | 3.30810194 |
14 | Papillary thyroid carcinoma (HP:0002895) | 3.30094282 |
15 | Atonic seizures (HP:0010819) | 3.26708233 |
16 | Purpura (HP:0000979) | 3.20234934 |
17 | Stomach cancer (HP:0012126) | 3.12677316 |
18 | Medial flaring of the eyebrow (HP:0010747) | 3.10313012 |
19 | Thyroid carcinoma (HP:0002890) | 3.04229651 |
20 | Nephrogenic diabetes insipidus (HP:0009806) | 2.98277097 |
21 | Congenital primary aphakia (HP:0007707) | 2.95409879 |
22 | Gait imbalance (HP:0002141) | 2.92148293 |
23 | Prostate neoplasm (HP:0100787) | 2.86492567 |
24 | Abnormality of T cell number (HP:0011839) | 2.85491528 |
25 | T lymphocytopenia (HP:0005403) | 2.77326081 |
26 | Pancreatic fibrosis (HP:0100732) | 2.71110793 |
27 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.66965585 |
28 | Absent/shortened dynein arms (HP:0200106) | 2.66965585 |
29 | Abnormality of the prostate (HP:0008775) | 2.66831289 |
30 | Retrobulbar optic neuritis (HP:0100654) | 2.66703895 |
31 | Optic neuritis (HP:0100653) | 2.66703895 |
32 | Spontaneous hematomas (HP:0007420) | 2.66055349 |
33 | Failure to thrive in infancy (HP:0001531) | 2.66052657 |
34 | Recurrent abscess formation (HP:0002722) | 2.63472056 |
35 | Oligomenorrhea (HP:0000876) | 2.63462639 |
36 | Autoimmune hemolytic anemia (HP:0001890) | 2.62222413 |
37 | Acute necrotizing encephalopathy (HP:0006965) | 2.60555647 |
38 | Leukocytosis (HP:0001974) | 2.60386943 |
39 | Abnormality of eosinophils (HP:0001879) | 2.59908493 |
40 | Submucous cleft hard palate (HP:0000176) | 2.59442778 |
41 | IgG deficiency (HP:0004315) | 2.56066225 |
42 | Poor coordination (HP:0002370) | 2.54152867 |
43 | Irregular epiphyses (HP:0010582) | 2.53345573 |
44 | Fetal akinesia sequence (HP:0001989) | 2.50546769 |
45 | Recurrent bacterial skin infections (HP:0005406) | 2.48854678 |
46 | Severe combined immunodeficiency (HP:0004430) | 2.48032201 |
47 | Abnormal ciliary motility (HP:0012262) | 2.47877166 |
48 | Thyroiditis (HP:0100646) | 2.46932996 |
49 | Episodic fever (HP:0001954) | 2.46138803 |
50 | Progressive macrocephaly (HP:0004481) | 2.45086684 |
51 | Eczematoid dermatitis (HP:0000976) | 2.44461576 |
52 | Tongue fasciculations (HP:0001308) | 2.43249182 |
53 | Alveolar cell carcinoma (HP:0006519) | 2.41269533 |
54 | Joint swelling (HP:0001386) | 2.36485034 |
55 | Increased IgM level (HP:0003496) | 2.34745448 |
56 | Encephalitis (HP:0002383) | 2.34737005 |
57 | Epileptic encephalopathy (HP:0200134) | 2.33682988 |
58 | Azoospermia (HP:0000027) | 2.33298329 |
59 | Type 2 muscle fiber atrophy (HP:0003554) | 2.32593615 |
60 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.32037885 |
61 | Eosinophilia (HP:0001880) | 2.31329331 |
62 | Keratoconjunctivitis (HP:0001096) | 2.29637458 |
63 | Hyperlipoproteinemia (HP:0010980) | 2.29425813 |
64 | Vasculitis (HP:0002633) | 2.29020489 |
65 | True hermaphroditism (HP:0010459) | 2.28778877 |
66 | Pulmonary infiltrates (HP:0002113) | 2.28765509 |
67 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.25901943 |
68 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.22385205 |
69 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.22385205 |
70 | Poor suck (HP:0002033) | 2.21914926 |
71 | Conjunctival telangiectasia (HP:0000524) | 2.21562828 |
72 | Neuroendocrine neoplasm (HP:0100634) | 2.17490129 |
73 | Genital tract atresia (HP:0001827) | 2.16878538 |
74 | Abnormality of T cells (HP:0002843) | 2.16434428 |
75 | Renal cortical cysts (HP:0000803) | 2.16381278 |
76 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.16251282 |
77 | Pustule (HP:0200039) | 2.15863691 |
78 | Dyschromatopsia (HP:0007641) | 2.15826971 |
79 | Pheochromocytoma (HP:0002666) | 2.14545520 |
80 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12177367 |
81 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12177367 |
82 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12177367 |
83 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12175925 |
84 | Rhinitis (HP:0012384) | 2.12104099 |
85 | Short nail (HP:0001799) | 2.09521809 |
86 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09324192 |
87 | Decreased central vision (HP:0007663) | 2.07748488 |
88 | Vertigo (HP:0002321) | 2.07180445 |
89 | Abnormality of the femoral head (HP:0003368) | 2.06827875 |
90 | Abnormality of incisor morphology (HP:0011063) | 2.06449682 |
91 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.04769098 |
92 | Bradycardia (HP:0001662) | 2.04069019 |
93 | Vaginal atresia (HP:0000148) | 2.03391476 |
94 | Hemoptysis (HP:0002105) | 2.02947605 |
95 | Metaphyseal dysplasia (HP:0100255) | 2.02168217 |
96 | Papilledema (HP:0001085) | 2.00746622 |
97 | Recurrent fungal infections (HP:0002841) | 2.00149985 |
98 | Hypoplasia of the fovea (HP:0007750) | 2.00061687 |
99 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.00061687 |
100 | Abnormal platelet function (HP:0011869) | 1.99820503 |
101 | Impaired platelet aggregation (HP:0003540) | 1.99820503 |
102 | Abnormality of the labia minora (HP:0012880) | 1.99475328 |
103 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98723945 |
104 | Muscle fibrillation (HP:0010546) | 1.98239665 |
105 | Granulocytopenia (HP:0001913) | 1.97640625 |
106 | Chronic diarrhea (HP:0002028) | 1.97319949 |
107 | Mitochondrial inheritance (HP:0001427) | 1.96814590 |
108 | Progressive inability to walk (HP:0002505) | 1.96388817 |
109 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.94941918 |
110 | Fair hair (HP:0002286) | 1.94752763 |
111 | Cystic hygroma (HP:0000476) | 1.94163978 |
112 | Chest pain (HP:0100749) | 1.93159891 |
113 | Arterial thrombosis (HP:0004420) | 1.92537943 |
114 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.92426652 |
115 | Hematochezia (HP:0002573) | 1.91326757 |
116 | Disproportionate short-trunk short stature (HP:0003521) | 1.91303094 |
117 | Orchitis (HP:0100796) | 1.91055628 |
118 | Curly hair (HP:0002212) | 1.90437420 |
119 | Autoimmune thrombocytopenia (HP:0001973) | 1.89138587 |
120 | Acute encephalopathy (HP:0006846) | 1.88767568 |
121 | Loss of speech (HP:0002371) | 1.88452829 |
122 | Meningitis (HP:0001287) | 1.88147256 |
123 | Abnormality of dental color (HP:0011073) | 1.87894893 |
124 | Flat capital femoral epiphysis (HP:0003370) | 1.87563192 |
125 | Recurrent sinusitis (HP:0011108) | 1.87184105 |
126 | Progressive cerebellar ataxia (HP:0002073) | 1.86832690 |
127 | Gangrene (HP:0100758) | 1.86027185 |
128 | Pulmonary fibrosis (HP:0002206) | 1.85963505 |
129 | Amyotrophic lateral sclerosis (HP:0007354) | 1.85612166 |
130 | 3-Methylglutaconic aciduria (HP:0003535) | 1.85514823 |
131 | Chronic sinusitis (HP:0011109) | 1.85153204 |
132 | Dysautonomia (HP:0002459) | 1.83542931 |
133 | Generalized hypopigmentation of hair (HP:0011358) | 1.82483630 |
134 | Polyphagia (HP:0002591) | 1.82374430 |
135 | Abnormal spermatogenesis (HP:0008669) | 1.82161106 |
136 | Absence seizures (HP:0002121) | 1.81751785 |
137 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.81352548 |
138 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.80625205 |
139 | Male infertility (HP:0003251) | 1.80247776 |
140 | Abnormality of binocular vision (HP:0011514) | 1.79602821 |
141 | Diplopia (HP:0000651) | 1.79602821 |
142 | Pulmonary embolism (HP:0002204) | 1.79508292 |
143 | Hypophosphatemic rickets (HP:0004912) | 1.78494373 |
144 | Mutism (HP:0002300) | 1.78090074 |
145 | Polyneuropathy (HP:0001271) | 1.76583697 |
146 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.75919098 |
147 | Widely spaced teeth (HP:0000687) | 1.75589553 |
148 | Hypoproteinemia (HP:0003075) | 1.74845095 |
149 | Hyperventilation (HP:0002883) | 1.74787752 |
150 | Increased CSF lactate (HP:0002490) | 1.74443515 |
151 | Infertility (HP:0000789) | 1.74332202 |
152 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73347425 |
153 | Obstructive lung disease (HP:0006536) | 1.73347425 |
154 | Recurrent skin infections (HP:0001581) | 1.73275072 |
155 | Abnormality of T cell physiology (HP:0011840) | 1.73078568 |
156 | Generalized tonic-clonic seizures (HP:0002069) | 1.72463464 |
157 | Hepatocellular necrosis (HP:0001404) | 1.68653365 |
158 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.68249196 |
159 | Abnormality of femoral epiphyses (HP:0006499) | 1.68249196 |
160 | Birth length less than 3rd percentile (HP:0003561) | 1.66914918 |
161 | Abnormality of the fovea (HP:0000493) | 1.66430241 |
162 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66173226 |
163 | Focal seizures (HP:0007359) | 1.65395348 |
164 | Pancreatic cysts (HP:0001737) | 1.64789851 |
165 | Dialeptic seizures (HP:0011146) | 1.64450659 |
166 | Vacuolated lymphocytes (HP:0001922) | 1.64077453 |
167 | Vertebral compression fractures (HP:0002953) | 1.62224443 |
168 | Type I transferrin isoform profile (HP:0003642) | 1.60711585 |
169 | Adrenal hypoplasia (HP:0000835) | 1.59657969 |
170 | Broad foot (HP:0001769) | 1.59291472 |
171 | Barrel-shaped chest (HP:0001552) | 1.59164477 |
172 | Muscle fiber atrophy (HP:0100295) | 1.59144724 |
173 | Blue irides (HP:0000635) | 1.57614110 |
174 | Keratoconjunctivitis sicca (HP:0001097) | 1.57421558 |
175 | Myositis (HP:0100614) | 1.57235061 |
176 | Prolonged neonatal jaundice (HP:0006579) | 1.55583637 |
177 | Diminished movement (HP:0002374) | 1.55544896 |
178 | Tetraparesis (HP:0002273) | 1.55387772 |
179 | Abnormality of macrophages (HP:0004311) | 1.54721260 |
180 | Decreased muscle mass (HP:0003199) | 1.52757291 |
181 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.50929834 |
182 | Glucose intolerance (HP:0000833) | 1.50013135 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SIK3 | 4.69322790 |
2 | CASK | 3.46188006 |
3 | BMPR2 | 3.05104383 |
4 | AKT3 | 2.97752409 |
5 | MAP3K12 | 2.90207606 |
6 | MAP3K14 | 2.76223507 |
7 | BCR | 2.68586904 |
8 | PRPF4B | 2.45856541 |
9 | SGK2 | 2.32854864 |
10 | MAP2K7 | 2.30311925 |
11 | TRIM28 | 2.23135587 |
12 | ARAF | 2.15505030 |
13 | PLK2 | 2.09144243 |
14 | STK38L | 2.01538998 |
15 | ERBB3 | 1.96389826 |
16 | FES | 1.94074580 |
17 | MUSK | 1.81803162 |
18 | IRAK3 | 1.78482939 |
19 | BMPR1B | 1.74135092 |
20 | RIPK4 | 1.74001684 |
21 | BTK | 1.73418118 |
22 | ZAK | 1.68330951 |
23 | SGK223 | 1.68192095 |
24 | SGK494 | 1.68192095 |
25 | NEK9 | 1.67733092 |
26 | BRAF | 1.67556420 |
27 | GRK6 | 1.63567786 |
28 | STK24 | 1.52330002 |
29 | ZAP70 | 1.51651595 |
30 | MAP4K2 | 1.51091049 |
31 | ITK | 1.49357082 |
32 | FRK | 1.45281061 |
33 | MAP4K1 | 1.43469124 |
34 | HCK | 1.40429786 |
35 | NTRK3 | 1.38764530 |
36 | ADRBK2 | 1.37493260 |
37 | MST4 | 1.37108537 |
38 | EIF2AK1 | 1.33781175 |
39 | PLK4 | 1.29802580 |
40 | CSF1R | 1.29549907 |
41 | ERBB4 | 1.28573929 |
42 | PIK3CG | 1.28037258 |
43 | SGK3 | 1.27292988 |
44 | IRAK4 | 1.26658097 |
45 | NEK6 | 1.23845285 |
46 | PINK1 | 1.20845668 |
47 | MINK1 | 1.19353151 |
48 | JAK1 | 1.11405097 |
49 | PIM2 | 1.08790838 |
50 | KSR1 | 1.08048689 |
51 | MAPK13 | 1.07006444 |
52 | PTK2B | 1.06801078 |
53 | MAP3K6 | 1.03682484 |
54 | MAP3K4 | 1.02005937 |
55 | TXK | 0.97785170 |
56 | LYN | 0.97371547 |
57 | CDK19 | 0.97360470 |
58 | TYK2 | 0.95944985 |
59 | GRK7 | 0.92635566 |
60 | LCK | 0.92450251 |
61 | KIT | 0.90248274 |
62 | CDK8 | 0.90201220 |
63 | PRKCE | 0.89921968 |
64 | CSK | 0.89646233 |
65 | TRPM7 | 0.88799670 |
66 | YES1 | 0.88326799 |
67 | EPHA3 | 0.87651417 |
68 | PBK | 0.87628636 |
69 | MAPK15 | 0.87293969 |
70 | CHUK | 0.85453051 |
71 | PAK3 | 0.85141399 |
72 | EPHB1 | 0.84519416 |
73 | GRK5 | 0.83861348 |
74 | ACVR1B | 0.82093367 |
75 | OXSR1 | 0.81488010 |
76 | IKBKE | 0.80096116 |
77 | PLK3 | 0.77368975 |
78 | MOS | 0.75263092 |
79 | FER | 0.73787760 |
80 | PRKCQ | 0.72303128 |
81 | GRK1 | 0.71367912 |
82 | MAP3K5 | 0.67866093 |
83 | BLK | 0.67278021 |
84 | MYLK | 0.66335582 |
85 | MAPK7 | 0.65581704 |
86 | VRK1 | 0.65498287 |
87 | IRAK1 | 0.65374854 |
88 | PRKD3 | 0.64935464 |
89 | IKBKB | 0.63471855 |
90 | CDK3 | 0.62402571 |
91 | MKNK2 | 0.60997430 |
92 | JAK2 | 0.60256837 |
93 | NME1 | 0.59844465 |
94 | DYRK2 | 0.57235925 |
95 | WNK3 | 0.56040786 |
96 | ADRBK1 | 0.53468348 |
97 | FLT3 | 0.53293842 |
98 | IRAK2 | 0.52455143 |
99 | TGFBR2 | 0.52052893 |
100 | ABL1 | 0.51420804 |
101 | PDK1 | 0.50664558 |
102 | IGF1R | 0.50276912 |
103 | EIF2AK3 | 0.50247846 |
104 | FGFR3 | 0.50094019 |
105 | JAK3 | 0.49567707 |
106 | MAP2K4 | 0.49467139 |
107 | FGR | 0.49373959 |
108 | INSRR | 0.48980855 |
109 | CAMK2A | 0.48626804 |
110 | HIPK2 | 0.48047395 |
111 | TIE1 | 0.47935882 |
112 | BRSK2 | 0.46991933 |
113 | MARK3 | 0.46751719 |
114 | EGFR | 0.46423987 |
115 | CAMKK2 | 0.46323760 |
116 | TNIK | 0.45608699 |
117 | MAP2K1 | 0.45521282 |
118 | LATS2 | 0.44117244 |
119 | STK3 | 0.43800406 |
120 | PRKG1 | 0.43391632 |
121 | PDK2 | 0.43190331 |
122 | TEC | 0.42946365 |
123 | LIMK1 | 0.42688595 |
124 | DYRK1A | 0.42321674 |
125 | TNK2 | 0.41916091 |
126 | RPS6KB1 | 0.41784590 |
127 | MAP3K3 | 0.41720482 |
128 | TAOK3 | 0.41338130 |
129 | MAPKAPK3 | 0.40249295 |
130 | ABL2 | 0.40106130 |
131 | MATK | 0.39735494 |
132 | RPS6KA2 | 0.39672520 |
133 | PIK3CA | 0.39590600 |
134 | PIM1 | 0.39244498 |
135 | MAP3K1 | 0.39164308 |
136 | PRKCD | 0.38319293 |
137 | PRKD1 | 0.38058887 |
138 | MAP3K9 | 0.36521470 |
139 | DAPK1 | 0.36259036 |
140 | PRKCG | 0.35019994 |
141 | EIF2AK2 | 0.33604043 |
142 | MAP3K2 | 0.33346888 |
143 | SGK1 | 0.32985704 |
144 | MAP3K13 | 0.32460758 |
145 | RAF1 | 0.31062811 |
146 | TBK1 | 0.30369433 |
147 | NUAK1 | 0.30228862 |
148 | NLK | 0.27908625 |
149 | TSSK6 | 0.26171860 |
150 | DAPK2 | 0.25751843 |
151 | SYK | 0.24894426 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 4.05531955 |
2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.16424295 |
3 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.96630162 |
4 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.90937424 |
5 | Protein export_Homo sapiens_hsa03060 | 2.46538557 |
6 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.37254817 |
7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.13596216 |
8 | Phagosome_Homo sapiens_hsa04145 | 2.13589091 |
9 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.02156512 |
10 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.92840574 |
11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91127150 |
12 | Basal transcription factors_Homo sapiens_hsa03022 | 1.89429699 |
13 | Platelet activation_Homo sapiens_hsa04611 | 1.89266889 |
14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88718764 |
15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.77270750 |
16 | Olfactory transduction_Homo sapiens_hsa04740 | 1.74810493 |
17 | Allograft rejection_Homo sapiens_hsa05330 | 1.73808168 |
18 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.70538319 |
19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.70349391 |
20 | Nicotine addiction_Homo sapiens_hsa05033 | 1.67055490 |
21 | Proteasome_Homo sapiens_hsa03050 | 1.59371218 |
22 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47588903 |
23 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46514418 |
24 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.36205046 |
25 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35788449 |
26 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.33330491 |
27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.31347012 |
28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.29298619 |
29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.27842476 |
30 | Morphine addiction_Homo sapiens_hsa05032 | 1.26229118 |
31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25366860 |
32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.20777623 |
33 | Legionellosis_Homo sapiens_hsa05134 | 1.20103939 |
34 | Taste transduction_Homo sapiens_hsa04742 | 1.19533190 |
35 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.16471754 |
36 | GABAergic synapse_Homo sapiens_hsa04727 | 1.15806569 |
37 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09661054 |
38 | Phototransduction_Homo sapiens_hsa04744 | 1.08763080 |
39 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.08606545 |
40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.07667788 |
41 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.07241710 |
42 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03569305 |
43 | Lysosome_Homo sapiens_hsa04142 | 1.00563366 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00199747 |
45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.99489988 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 0.99139408 |
47 | Pertussis_Homo sapiens_hsa05133 | 0.98871959 |
48 | RNA polymerase_Homo sapiens_hsa03020 | 0.98649577 |
49 | Leishmaniasis_Homo sapiens_hsa05140 | 0.98409376 |
50 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.97779166 |
51 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.97620973 |
52 | Tuberculosis_Homo sapiens_hsa05152 | 0.97492898 |
53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.97255671 |
54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.96567589 |
55 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95194230 |
56 | Circadian entrainment_Homo sapiens_hsa04713 | 0.95023321 |
57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94435537 |
58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92570351 |
59 | Insulin secretion_Homo sapiens_hsa04911 | 0.92563265 |
60 | Renin secretion_Homo sapiens_hsa04924 | 0.90149054 |
61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90043299 |
62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.88621898 |
63 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.88309202 |
64 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84627763 |
65 | Influenza A_Homo sapiens_hsa05164 | 0.83007578 |
66 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82417904 |
67 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82155530 |
68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.80609645 |
69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.80552421 |
70 | Long-term potentiation_Homo sapiens_hsa04720 | 0.80087454 |
71 | Asthma_Homo sapiens_hsa05310 | 0.78588924 |
72 | Endocytosis_Homo sapiens_hsa04144 | 0.76914134 |
73 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76572758 |
74 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74947432 |
75 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.73660145 |
76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73548180 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.73400090 |
78 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.72246842 |
79 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71871966 |
80 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70793178 |
81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.70116645 |
82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.69917768 |
83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.68088232 |
84 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.68003799 |
85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.67875037 |
86 | Measles_Homo sapiens_hsa05162 | 0.65362179 |
87 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.65327721 |
88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65302456 |
89 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.64819964 |
90 | Malaria_Homo sapiens_hsa05144 | 0.62665413 |
91 | Salivary secretion_Homo sapiens_hsa04970 | 0.62616635 |
92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.62582581 |
93 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60979166 |
94 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.59874415 |
95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59439575 |
96 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59391923 |
97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57655980 |
98 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57358379 |
99 | Shigellosis_Homo sapiens_hsa05131 | 0.55882919 |
100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.55667961 |
101 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.54765451 |
102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53098331 |
103 | Long-term depression_Homo sapiens_hsa04730 | 0.51998928 |
104 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.51664116 |
105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.51425742 |
106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.50617526 |
107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49825392 |
108 | Thyroid cancer_Homo sapiens_hsa05216 | 0.47625862 |
109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47621233 |
110 | RNA degradation_Homo sapiens_hsa03018 | 0.46789445 |
111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46629056 |
112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.45804796 |
113 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45700382 |
114 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44850232 |
115 | Melanoma_Homo sapiens_hsa05218 | 0.44763016 |
116 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42960735 |
117 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42095460 |
118 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.41634889 |
119 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.41326541 |
120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.40190060 |
121 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.37074915 |
122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36607543 |
123 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35937904 |
124 | Hepatitis B_Homo sapiens_hsa05161 | 0.35733460 |
125 | Purine metabolism_Homo sapiens_hsa00230 | 0.35295697 |
126 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.33100177 |
127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31645844 |
128 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.31320892 |
129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.30293237 |
130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30221757 |
131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.29959208 |